| |
|
|
| |
|
| | | 
| | | Early Pharmacologic Intervention in Autism: A Randomized, Placebo-controlled Trial of Fluoxetine in Preschool Children. | Do you know a child who has recently been diagnosed with autism?
Does your child have difficulty with changes in routine, interacting
with others or intense interest in unusual things?
The ASPIRE Research program at the UNC-Chapel Hill's Department of
Psychiatry is recruiting children ages thirty to fifty-eight months
(2.5-5 years) for an autism treatment study. The study is a 12 month
study designed to assess whether or not overall functioning can be
improved with fluoxetine (Prozac) treatment.
Benefits for subjects include a comprehensive diagnostic assessment at
the beginning of the study. If the child meets criteria for autism and
has no medical contraindications to treatment in the study, they will
have a comprehensive cognitive and language assessment at baseline and
then again at three months, seven months, and twelve months of study
participation. Appointments with child psychiatrists who specialize in
autism spectrum disorders are provided free of charge to research
participants.
Enrollment for this particular study closes at the end of January 2007.
We are actively seeking participants for this important study until
then.
If you think this study may be appropriate for your child, please
contact us. We are happy to tell you more about our program and answer
any questions. Please call the ASPIRE Research Hotline (1-800-708-0048)
or email us at Lsikich@med.unc.edu.
This message has been reviewed by the UNC Biomedical IRB and was
approved as
of 11/20/2006 for IRB protocol # 05-1694 entitled: "Early Pharmacologic
Intervention in Autism: A Randomized, Placebo-controlled Trial of
Fluoxetine
in Preschool Children".
| | | | | | |
Return to search results
| |
|
|
| |
|
|
|
|
